
Please try another search
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Ramy Farid | 57 | 2008 | CEO, President & Director |
Nancy A. Thornberry | 66 | 2019 | Independent Director |
Michael M. Lynton | 62 | 2018 | Independent Chairman of the Board |
Jeffrey Allan Chodakewitz | 66 | 2020 | Independent Director |
Rosana Kapeller-Libermann | 58 | 2019 | Independent Director |
Gary L. Ginsberg | 59 | 2020 | Independent Director |
Gary L. Sender | 60 | 2019 | Independent Director |
Brian Shoichet | - | - | Scientific Advisor |
Pratyush Tiwary | - | 2023 | Scientific Advisor |
Barry Honig | - | - | Scientific Advisor |
Arun Oberoi | 70 | 2022 | Independent Director |
Bridget A. van Kralingen | 61 | 2025 | Director |
Richard A. Friesner | 72 | 1990 | Co-Founder, Scientific Advisory Chairman and Director |
William Goddard | - | - | Co-Founder & Scientific Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review